DVT 中每日两次和一次 SUB Q 依诺肝素和连续静脉注射肝素-猫眼课题宝

DVT 中每日两次和一次 SUB Q 依诺肝素和连续静脉注射肝素

批准号：

2787275

负责人：

金额：

$2.4万

依托单位：

SCRIPPS RESEARCH INSTITUTE, THE

依托单位国家：

美国

项目类别：

财政年份：

资助国家：

美国

项目状态：

未结题

起止时间：

至

来源：

https://reporter.nih.gov/project-details/2787275

关键词：

anticoagulants cardiovascular disorder chemotherapy clinical research dosage drug administration rate /duration drug screening /evaluation health care cost /financing heparin human subject human therapy evaluation intravenous administration relapse /recurrence socioeconomics thromboembolism venous thrombosis

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

This aims to compare the safety, efficacy and cost benefit of enoxaparin administered once or twice daily subcutaneously to intravenous continuous-infusion heparin therapy in the treatment of lower extremity deep vein thrombosis and pulmonary embolism. Efficacy will be measured by the incidence of recurrence of any documented venous thromboembolism in all treated patients completing the study. Socioeconomic measurement will be the total health care costs.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文

TWICE AND ONCE DAILY SUB Q ENOXAPARIN AND CONTINUOUS IV HEPARIN IN DVT

项目摘要

项目成果

相关文献